Please assess the completion status of the following clinical trial:

Trial Title: Perineural Local Anesthetic Administration With a Continuous Infusion Versus Automatic Intermittent Boluses

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients undergoing painful foot and/or ankle surgery with a planned popliteal sciatic perineural catheter for postoperative analgesia~* age 18 years or older.~Exclusion Criteria:~* Current daily opioid use within the previous 4 weeks~* Clinical neuro-muscular deficit of either the sciatic nerve and its branches and/or innervating muscles~* Morbid obesity \[weight \> 35 kg/m2\]; surgery outside of ipsilateral sciatic and saphenous nerve distributions~* Pregnancy \[as determined by a urine pregnancy test prior to any study interventions\]~* Incarceration.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Continuous Infusion (Type: ACTIVE_COMPARATOR): Patients will receive a continuous infusion of Ropivacaine 0.2% (6 mL/hr, 4 mL patient controlled bolus with 30-minute lockout).
- Automated Boluses (Type: EXPERIMENTAL): Patients will receive intermittent boluses of Ropivacaine 0.2% (8 mL automated bolus every 120 minutes, 4 mL patient controlled bolus with 30-minute lockout).

Based on this trial design, predict the completion outcome and termination type (if applicable).